These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 9640472)

  • 21. Real time detection of photoreactivity in pharmaceutical solids and solutions with isothermal microcalorimetry.
    Lehto VP; Salonen J; Laine E
    Pharm Res; 1999 Mar; 16(3):368-73. PubMed ID: 10213366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nifedipine in semi-solid formulations for topical use in peripheral vascular disease: preparation, characterization, and permeation assay.
    Santis AK; de Freitas ZM; Ricci-Junior E; de Brito-Gitirana L; Fonseca LB; Santos EP
    Drug Dev Ind Pharm; 2013 Jul; 39(7):1098-106. PubMed ID: 22901029
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Stability of gabapentin in extemporaneously compounded oral suspensions.
    Friciu M; Roullin VG; Leclair G
    PLoS One; 2017; 12(4):e0175208. PubMed ID: 28414771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymer blends used to prepare nifedipine loaded hollow microspheres for a floating-type oral drug delivery system: in vitro evaluation.
    Zhao L; Wei YM; Yu Y; Zheng WW
    Arch Pharm Res; 2010 Mar; 33(3):443-50. PubMed ID: 20361310
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro dissolution studies on nifedipine capsules.
    Mehta AC; Hart-Davies S; Kay EA
    J Clin Pharm Ther; 1995 Aug; 20(4):243-5. PubMed ID: 8557790
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stability of labetalol hydrochloride, metoprolol tartrate, verapamil hydrochloride, and spironolactone with hydrochlorothiazide in extemporaneously compounded oral liquids.
    Allen LV; Erickson MA
    Am J Health Syst Pharm; 1996 Oct; 53(19):2304-9. PubMed ID: 8893069
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug-polymer interaction and its significance on the physical stability of nifedipine amorphous dispersion in microparticles of an ammonio methacrylate copolymer and ethylcellulose binary blend.
    Huang J; Wigent RJ; Schwartz JB
    J Pharm Sci; 2008 Jan; 97(1):251-62. PubMed ID: 17724668
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Development of nifedipine-loaded coated gelatin microcapsule as a long acting oral delivery.
    Li DX; Kim JO; Oh DH; Lee WS; Hong MJ; Kang JY; Choi JS; Woo JS; Yong CS; Choi HG
    Arch Pharm Res; 2009 Jan; 32(1):127-32. PubMed ID: 19183885
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparison of the physical stability of amorphous felodipine and nifedipine systems.
    Marsac PJ; Konno H; Taylor LS
    Pharm Res; 2006 Oct; 23(10):2306-16. PubMed ID: 16927182
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Suspensions as a Valuable Alternative to Extemporaneously Compounded Capsules.
    Dijkers E; Nanhekhan V; Thorissen A; Polonini H
    Int J Pharm Compd; 2017; 21(2):171-175. PubMed ID: 28346214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Common stem--dipine.
    Prescrire Int; 2011 Jan; 20(112):13. PubMed ID: 21462786
    [No Abstract]   [Full Text] [Related]  

  • 32. The interaction of nifedipine with selected cyclodextrins and the subsequent solubility-permeability trade-off.
    Beig A; Miller JM; Dahan A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1293-9. PubMed ID: 23770429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An investigation of nifedipine miscibility in solid dispersions using Raman spectroscopy.
    Keratichewanun S; Yoshihashi Y; Sutanthavibul N; Terada K; Chatchawalsaisin J
    Pharm Res; 2015 Jul; 32(7):2458-73. PubMed ID: 25673042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stability of Diazoxide in Extemporaneously Compounded Oral Suspensions.
    Friciu M; Zaraa S; Roullin VG; Leclair G
    PLoS One; 2016; 11(10):e0164577. PubMed ID: 27727306
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Stability of flucytosine in an extemporaneously compounded oral liquid.
    Wintermeyer SM; Nahata MC
    Am J Health Syst Pharm; 1996 Feb; 53(4):407-9. PubMed ID: 8673661
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preparation and stabilization of nifedipine lipid nanoparticles.
    Kamiya S; Yamada M; Kurita T; Miyagishima A; Arakawa M; Sonobe T
    Int J Pharm; 2008 Apr; 354(1-2):242-7. PubMed ID: 18082344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Taming photo-induced oxidation degradation of dihydropyridine drugs through cocrystallization.
    Yu Q; Yan Z; Bao J; Wang JR; Mei X
    Chem Commun (Camb); 2017 Nov; 53(91):12266-12269. PubMed ID: 29058012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of laser irradiation on the stability of a photo-sensitive active pharmaceutical ingredient by Raman microscopy.
    Uchida H; Eguchi K; Otsuka M
    J Pharm Biomed Anal; 2012 Nov; 70():259-64. PubMed ID: 22840978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thermal stability of 1,4-dihydropyridine derivatives in solid state.
    Marciniec B; Ogrodowczyk M
    Acta Pol Pharm; 2006; 63(6):477-84. PubMed ID: 17438863
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel vesicular transdermal delivery of nifedipine - preparation, characterization and in vitro/in-vivo evaluation.
    Yasam VR; Jakki SL; Natarajan J; Venkatachalam S; Kuppusamy G; Sood S; Jain K
    Drug Deliv; 2016; 23(2):619-30. PubMed ID: 25005581
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.